Carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus.
Cogliano VJ, Corsini E, Fournier A, Nelson HH, Sergi CM, Antunes AMM, Cahoon EK, Chen G, Duarte-Salles T, Engels E, Fu J, Germolec D, Ghiasvand R, Hicks B, Jean-Claude BJ, Jena G, Lerche CM, Li X, Lupattelli A, Ong TP, Vega L, Withrow DR, Boxall ABA, Benbrahim-Tallaa L, de Conti A, Kunzmann A, Pasqual E, Wedekind R, Deng X, Mahamat-Saleh Y, Majidi A, Peruchet-Noray L, Rezende Da Silva J, Suonio E, Viegas S, Zhai Y, Mattock H, Facchin C, Schubauer-Berigan MK, Madia F.
Cogliano VJ, et al. Among authors: lupattelli a.
Lancet Oncol. 2024 Nov 28:S1470-2045(24)00685-5. doi: 10.1016/S1470-2045(24)00685-5. Online ahead of print.
Lancet Oncol. 2024.
PMID: 39622256
No abstract available.